NEWS

WIRES

OTHER

Nuvilex, Inc. Announces Distribution Agreement for Cinnergen in China and Canada

The Nuvilex Cinnergen^TM product provides a synergistic and holistic approach to managing blood sugar levels by combining many nutrients from concentrated herbal food sources. Cinnergen provides the body with essential amino acids, vitamins, enzymes, minerals, bioflavonoids, antioxidants, and phytochemicals. All are isolated from natural sources, not created synthetically, and are optimal for the body's use. As the body becomes more efficient, overall health can be improved.

The Agreement with GGS, which runs through June 2020, will allow GGS to register, license and market Cinnergen in both countries. GGS has created an established sales network through Canada with over 3,500 business clients. In addition, it is one of the few Western companies making inroads to distribution of herbal-based products in mainland China.

A GGS Holdings representative commented that GGS is one of the few companies having the proven ability to enter the Chinese marketplace and brand products throughout China. GGS has already been successful in Canada and China in launching, distributing and branding several herbal products and strongly believes Cinnergen is an ideal product for enhancing the rapidly expanding international organic herbal market. At present, Nuvilex and GGS anticipate orders for Cinnergen will commence during the first fiscal quarter.

Dr. Robert F. Ryan, CEO of Nuvilex, added, "The GGS agreement complements our overall strategy by launching the successful Cinnergen product into markets where Nuvilex doesn't have a current presence. With the GGS partnership, upfront registration and licensing establishment costs associated with these new distribution channels have been paid for by GGS, allowing Nuvilex to support GGS while dramatically expanding Cinnergen-based revenues and ultimately lowered risk and no expense. A key component in driving Nuvilex forward is capitalizing on our completed research, development, and existing product lines, and ultimately building strong distribution channels to ensure market fulfillment. Partnering with GGS, a company with a proven track record in marketing, branding new products and distribution of herbal supplements in the international market, is the first of many steps we are already involved in. We anticipate building sales through establishing a sales network that can translate into immediate results as new products are brought to market. We ultimately are looking to increase revenue through care for our customers, our company, and the investors who have stood by and continue to support Nuvilex."

About Nuvilex, Inc.

Nuvilex, Inc. is a Green products company. The Company's current products include Cinnergen , which promotes a healthy glucose metabolism; Cinnechol , designed to help balance triglycerides and support cardiovascular function; Oraphyte , an all-natural nematocide product line, highly effective in combating nematodes harmful to grass and plant growth; Citroxin , a safe, non-toxic, all-natural product line capable of killing bacteria, virus, and fungus, even including Avian Flu and MRSA (Methicillin-resistant Staphylococcus aureus); Reme-Flu , a unique, two-part homeopathic medicine for preventing and treating symptoms of flu manufactured by Legacy Biotechnologies, Inc.; Talsyn , a unique, all natural Lipid-Peptide combination of ingredients used for the management of keloids, hypertrophic scars, erythema and surgical incisions; and Infinitink, a permanent, yet more easily removable, tattoo ink.

Shareholders and all persons interested in monitoring the progress of our company as we move forward are encouraged to subscribe to the electronic mailing list by submitting their email address to investors@nuvilex.com.

Marmel Communications, LLC
Marlin Molinaro, 702-434-8692 (Investor Relations)
mmolinarofc@aol.com